vs
Side-by-side financial comparison of REGIS CORP (RGS) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
RHYTHM PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($57.3M vs $57.1M, roughly 1.0× REGIS CORP). REGIS CORP runs the higher net margin — 0.8% vs -83.0%, a 83.8% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs 22.3%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 7.8%).
REGIS CORPRGSEarnings & Financial Report
Regis Corporation is an American operator of hair salons. As of August 2021, it has 5,563 franchised and 276 company-owned salons. Its headquarters are in Minneapolis, Minnesota.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
RGS vs RYTM — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $57.1M | $57.3M |
| Net Profit | $456.0K | $-47.5M |
| Gross Margin | — | 91.6% |
| Operating Margin | 10.8% | -82.2% |
| Net Margin | 0.8% | -83.0% |
| Revenue YoY | 22.3% | 36.9% |
| Net Profit YoY | -94.0% | -9.6% |
| EPS (diluted) | $0.16 | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $57.1M | $57.3M | ||
| Q3 25 | $59.0M | $51.3M | ||
| Q2 25 | $60.4M | $48.5M | ||
| Q1 25 | $57.0M | $32.7M | ||
| Q4 24 | $46.7M | $41.8M | ||
| Q3 24 | $46.1M | $33.3M | ||
| Q2 24 | $49.4M | $29.1M | ||
| Q1 24 | $49.2M | $26.0M |
| Q4 25 | $456.0K | $-47.5M | ||
| Q3 25 | $1.4M | $-52.9M | ||
| Q2 25 | $116.5M | $-46.6M | ||
| Q1 25 | $250.0K | $-49.5M | ||
| Q4 24 | $7.6M | $-43.3M | ||
| Q3 24 | $-853.0K | $-43.6M | ||
| Q2 24 | $91.2M | $-32.3M | ||
| Q1 24 | $-2.3M | $-141.4M |
| Q4 25 | — | 91.6% | ||
| Q3 25 | — | 89.3% | ||
| Q2 25 | — | 88.6% | ||
| Q1 25 | — | 88.8% | ||
| Q4 24 | — | 90.9% | ||
| Q3 24 | — | 88.5% | ||
| Q2 24 | — | 89.9% | ||
| Q1 24 | — | 89.2% |
| Q4 25 | 10.8% | -82.2% | ||
| Q3 25 | 10.0% | -102.6% | ||
| Q2 25 | 12.1% | -93.4% | ||
| Q1 25 | 8.8% | -143.7% | ||
| Q4 24 | 11.8% | -98.6% | ||
| Q3 24 | 4.6% | -132.0% | ||
| Q2 24 | — | -139.2% | ||
| Q1 24 | 8.3% | -538.7% |
| Q4 25 | 0.8% | -83.0% | ||
| Q3 25 | 2.3% | -103.1% | ||
| Q2 25 | 192.9% | -96.1% | ||
| Q1 25 | 0.4% | -151.4% | ||
| Q4 24 | 16.4% | -103.6% | ||
| Q3 24 | -1.9% | -131.2% | ||
| Q2 24 | 184.7% | -110.9% | ||
| Q1 24 | -4.7% | -544.4% |
| Q4 25 | $0.16 | $-0.73 | ||
| Q3 25 | $0.49 | $-0.82 | ||
| Q2 25 | $43.67 | $-0.75 | ||
| Q1 25 | $0.08 | $-0.81 | ||
| Q4 24 | $2.71 | $-0.71 | ||
| Q3 24 | $-0.36 | $-0.73 | ||
| Q2 24 | $38.40 | $-0.55 | ||
| Q1 24 | $-1.00 | $-2.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.4M | $388.9M |
| Total DebtLower is stronger | $113.3M | — |
| Stockholders' EquityBook value | $188.7M | $139.1M |
| Total Assets | $588.3M | $480.2M |
| Debt / EquityLower = less leverage | 0.60× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.4M | $388.9M | ||
| Q3 25 | $16.6M | $416.1M | ||
| Q2 25 | $17.0M | $291.0M | ||
| Q1 25 | $13.3M | $314.5M | ||
| Q4 24 | $10.2M | $320.6M | ||
| Q3 24 | $6.3M | $298.4M | ||
| Q2 24 | $10.1M | $319.1M | ||
| Q1 24 | $5.9M | $201.2M |
| Q4 25 | $113.3M | — | ||
| Q3 25 | $111.3M | — | ||
| Q2 25 | $110.8M | — | ||
| Q1 25 | $112.0M | — | ||
| Q4 24 | $111.5M | — | ||
| Q3 24 | $95.2M | — | ||
| Q2 24 | $99.5M | — | ||
| Q1 24 | $179.7M | — |
| Q4 25 | $188.7M | $139.1M | ||
| Q3 25 | $187.6M | $148.8M | ||
| Q2 25 | $185.6M | $-11.9M | ||
| Q1 25 | $68.6M | $18.9M | ||
| Q4 24 | $66.7M | $21.7M | ||
| Q3 24 | $56.4M | $11.2M | ||
| Q2 24 | $56.8M | $39.3M | ||
| Q1 24 | $-35.8M | $61.6M |
| Q4 25 | $588.3M | $480.2M | ||
| Q3 25 | $592.1M | $506.9M | ||
| Q2 25 | $599.0M | $372.7M | ||
| Q1 25 | $511.2M | $386.7M | ||
| Q4 24 | $530.1M | $392.3M | ||
| Q3 24 | $508.9M | $363.6M | ||
| Q2 24 | $530.5M | $381.8M | ||
| Q1 24 | $543.7M | $258.7M |
| Q4 25 | 0.60× | — | ||
| Q3 25 | 0.59× | — | ||
| Q2 25 | 0.60× | — | ||
| Q1 25 | 1.63× | — | ||
| Q4 24 | 1.67× | — | ||
| Q3 24 | 1.69× | — | ||
| Q2 24 | 1.75× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.7M | $-25.4M |
| Free Cash FlowOCF − Capex | $891.0K | — |
| FCF MarginFCF / Revenue | 1.6% | — |
| Capex IntensityCapex / Revenue | 1.4% | — |
| Cash ConversionOCF / Net Profit | 3.65× | — |
| TTM Free Cash FlowTrailing 4 quarters | $14.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7M | $-25.4M | ||
| Q3 25 | $2.3M | $-26.6M | ||
| Q2 25 | $6.8M | $-23.3M | ||
| Q1 25 | $6.2M | $-40.4M | ||
| Q4 24 | $2.1M | $-18.8M | ||
| Q3 24 | $-1.3M | $-25.2M | ||
| Q2 24 | $5.1M | $-29.1M | ||
| Q1 24 | $-277.0K | $-40.7M |
| Q4 25 | $891.0K | — | ||
| Q3 25 | $1.9M | — | ||
| Q2 25 | $6.2M | — | ||
| Q1 25 | $5.9M | — | ||
| Q4 24 | $1.7M | — | ||
| Q3 24 | $-1.4M | — | ||
| Q2 24 | $5.1M | — | ||
| Q1 24 | $-326.0K | — |
| Q4 25 | 1.6% | — | ||
| Q3 25 | 3.2% | — | ||
| Q2 25 | 10.3% | — | ||
| Q1 25 | 10.3% | — | ||
| Q4 24 | 3.6% | — | ||
| Q3 24 | -3.0% | — | ||
| Q2 24 | 10.3% | — | ||
| Q1 24 | -0.7% | — |
| Q4 25 | 1.4% | — | ||
| Q3 25 | 0.7% | — | ||
| Q2 25 | 0.9% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 0.9% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.1% | — |
| Q4 25 | 3.65× | — | ||
| Q3 25 | 1.68× | — | ||
| Q2 25 | 0.06× | — | ||
| Q1 25 | 24.80× | — | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.06× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
RGS
| Franchise Segment | $37.9M | 66% |
| Royalty | $13.6M | 24% |
| Other | $2.8M | 5% |
| Fees | $1.8M | 3% |
| Franchise Fees | $1.0M | 2% |
RYTM
Segment breakdown not available.
